114 related articles for article (PubMed ID: 36752344)
1. Inhibition of lysophosphatidic acid receptor 6 upregulated by the choline-deficient l-amino acid-defined diet prevents hepatocarcinogenesis in mice.
Gnocchi D; Afonso MB; Cavalluzzi MM; Lentini G; Ingravallo G; Sabbà C; Rodrigues CMP; Mazzocca A
Mol Carcinog; 2023 May; 62(5):577-582. PubMed ID: 36752344
[TBL] [Abstract][Full Text] [Related]
2. Distinct DNA methylation patterns of lysophosphatidic acid receptor genes during rat hepatocarcinogenesis induced by a choline-deficient L-amino acid-defined diet.
Okabe K; Hayashi M; Yoshida I; Nishimura K; Fukushima N; Tsujiuchi T
Arch Toxicol; 2011 Oct; 85(10):1303-10. PubMed ID: 21290119
[TBL] [Abstract][Full Text] [Related]
3. Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice.
Wang B; Majumder S; Nuovo G; Kutay H; Volinia S; Patel T; Schmittgen TD; Croce C; Ghoshal K; Jacob ST
Hepatology; 2009 Oct; 50(4):1152-61. PubMed ID: 19711427
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular carcinoma in a mouse model fed a choline-deficient, L-amino acid-defined, high-fat diet.
Ikawa-Yoshida A; Matsuo S; Kato A; Ohmori Y; Higashida A; Kaneko E; Matsumoto M
Int J Exp Pathol; 2017 Aug; 98(4):221-233. PubMed ID: 28895242
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of LPAR6 overcomes sorafenib resistance by switching glycolysis into oxidative phosphorylation in hepatocellular carcinoma.
Gnocchi D; Kurzyk A; Mintrone A; Lentini G; Sabbà C; Mazzocca A
Biochimie; 2022 Nov; 202():180-189. PubMed ID: 35952946
[TBL] [Abstract][Full Text] [Related]
6. A distinctive protein signature induced by lysophosphatidic acid receptor 6 (LPAR6) expression in hepatocellular carcinoma cells.
Lippolis R; Gnocchi D; Santacroce L; Siciliano RA; Mazzeo MF; Scacco S; Sabbà C; Mazzocca A
Biochem Biophys Res Commun; 2020 Jun; 526(4):1150-1156. PubMed ID: 32321639
[TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidic acid receptor LPAR6 supports the tumorigenicity of hepatocellular carcinoma.
Mazzocca A; Dituri F; De Santis F; Filannino A; Lopane C; Betz RC; Li YY; Mukaida N; Winter P; Tortorella C; Giannelli G; Sabbà C
Cancer Res; 2015 Feb; 75(3):532-43. PubMed ID: 25589345
[TBL] [Abstract][Full Text] [Related]
8. Novel lysophosphatidic acid receptor 6 antagonists inhibit hepatocellular carcinoma growth through affecting mitochondrial function.
Gnocchi D; Kapoor S; Nitti P; Cavalluzzi MM; Lentini G; Denora N; Sabbà C; Mazzocca A
J Mol Med (Berl); 2020 Feb; 98(2):179-191. PubMed ID: 31863151
[TBL] [Abstract][Full Text] [Related]
9. Xanthenylacetic Acid Derivatives Effectively Target Lysophosphatidic Acid Receptor 6 to Inhibit Hepatocellular Carcinoma Cell Growth.
Gnocchi D; Cavalluzzi MM; Mangiatordi GF; Rizzi R; Tortorella C; Spennacchio M; Lentini G; Altomare A; Sabbà C; Mazzocca A
ChemMedChem; 2021 Jul; 16(13):2121-2129. PubMed ID: 33831272
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II type 1 receptor antagonist prevents hepatic carcinoma in rats with nonalcoholic steatohepatitis.
Tamaki Y; Nakade Y; Yamauchi T; Makino Y; Yokohama S; Okada M; Aso K; Kanamori H; Ohashi T; Sato K; Nakao H; Haneda M; Yoneda M
J Gastroenterol; 2013 Apr; 48(4):491-503. PubMed ID: 22886508
[TBL] [Abstract][Full Text] [Related]
11. A Cholecystokinin Receptor Antagonist Halts Nonalcoholic Steatohepatitis and Prevents Hepatocellular Carcinoma.
Tucker RD; Ciofoaia V; Nadella S; Gay MD; Cao H; Huber M; Safronenka A; Shivapurkar N; Kallakury B; Kruger AJ; Kroemer AHK; Smith JP
Dig Dis Sci; 2020 Jan; 65(1):189-203. PubMed ID: 31297627
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of hyaluronan synthesis by 4-methylumbelliferone ameliorates non-alcoholic steatohepatitis in choline-deficient L-amino acid-defined diet-induced murine model.
Yang YM; Wang Z; Matsuda M; Seki E
Arch Pharm Res; 2021 Feb; 44(2):230-240. PubMed ID: 33486695
[TBL] [Abstract][Full Text] [Related]
13. Disturbance of DNA methylation patterns in the early phase of hepatocarcinogenesis induced by a choline-deficient L-amino acid-defined diet in rats.
Shimizu K; Onishi M; Sugata E; Sokuza Y; Mori C; Nishikawa T; Honoki K; Tsujiuchi T
Cancer Sci; 2007 Sep; 98(9):1318-22. PubMed ID: 17640295
[TBL] [Abstract][Full Text] [Related]
14. Comparison of murine steatohepatitis models identifies a dietary intervention with robust fibrosis, ductular reaction, and rapid progression to cirrhosis and cancer.
Wei G; An P; Vaid KA; Nasser I; Huang P; Tan L; Zhao S; Schuppan D; Popov YV
Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G174-G188. PubMed ID: 31630534
[TBL] [Abstract][Full Text] [Related]
15. Exogenous Administration of Low-Dose Lipopolysaccharide Potentiates Liver Fibrosis in a Choline-Deficient l-Amino-Acid-Defined Diet-Induced Murine Steatohepatitis Model.
Nakanishi K; Kaji K; Kitade M; Kubo T; Furukawa M; Saikawa S; Shimozato N; Sato S; Seki K; Kawaratani H; Moriya K; Namisaki T; Yoshiji H
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31163617
[TBL] [Abstract][Full Text] [Related]
16. Prevention by methionine of enhancement of hepatocarcinogenesis by coadministration of a choline-deficient L-amino acid-defined diet and ethionine in rats.
Tsujiuchi T; Kobayashi E; Nakae D; Mizumoto Y; Andoh N; Kitada H; Ohashi K; Fukuda T; Kido A; Tsutsumi M
Jpn J Cancer Res; 1995 Dec; 86(12):1136-42. PubMed ID: 8636001
[TBL] [Abstract][Full Text] [Related]
17. A trans fatty acid substitute enhanced development of liver proliferative lesions induced in mice by feeding a choline-deficient, methionine-lowered, L-amino acid-defined, high-fat diet.
Suzuki-Kemuriyama N; Abe A; Uno K; Ogawa S; Watanabe A; Sano R; Yuki M; Miyajima K; Nakae D
Lipids Health Dis; 2020 Dec; 19(1):251. PubMed ID: 33317575
[TBL] [Abstract][Full Text] [Related]
18. Fhit gene alterations in hepatocarcinogenesis induced by a choline-deficient L-amino acid-defined diet in rats.
Tsujiuchi T; Sasaki Y; Oka Y; Konishi Y; Tsutsumi M
Mol Carcinog; 2003 Mar; 36(3):147-52. PubMed ID: 12619037
[TBL] [Abstract][Full Text] [Related]
19. Development of hepatocellular adenomas and carcinomas associated with fibrosis in C57BL/6J male mice given a choline-deficient, L-amino acid-defined diet.
Denda A; Kitayama W; Kishida H; Murata N; Tsutsumi M; Tsujiuchi T; Nakae D; Konishi Y
Jpn J Cancer Res; 2002 Feb; 93(2):125-32. PubMed ID: 11856475
[TBL] [Abstract][Full Text] [Related]
20. Genetic inactivation of Nrf2 prevents clonal expansion of initiated cells in a nutritional model of rat hepatocarcinogenesis.
Orrù C; Szydlowska M; Taguchi K; Zavattari P; Perra A; Yamamoto M; Columbano A
J Hepatol; 2018 Sep; 69(3):635-643. PubMed ID: 29758334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
